av/vincerx-pharma--big.svg

COM:VINCERX

Vincerx Pharma, Inc.

  • Stock

Last Close

0.26

22/11 21:00

Market Cap

19.29M

Beta: -

Volume Today

228.99K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
cost of revenue
173.00K
-
915K
-
gross profit
-173.00K
-
-915K
-
selling and marketing expenses
44.95K
-
general and administrative expenses
54
-
3.60M
6,662,862.96%
22.57M
527.43%
18.95M
16.04%
13.64M
28.05%
selling general and administrative expenses
45K
-
3.60M
7,895.56%
22.57M
527.43%
18.95M
16.04%
13.64M
28.05%
research and development expenses
7.12M
-
40.08M
463.25%
52.15M
30.12%
28.06M
46.20%
other expenses
-8K
-
1.24M
15,600%
cost and expenses
45K
-
10.71M
23,708.89%
62.66M
484.80%
71.11M
13.48%
42.61M
40.08%
operating expenses
45K
-
10.71M
23,708.89%
62.66M
484.80%
71.11M
13.48%
41.69M
41.36%
interest expense
8K
-
-8.21M
-
ebitda
-45K
-
-10.71M
23,708.89%
-86.01M
702.82%
-74.94M
12.88%
-41.69M
44.36%
operating income
-45K
-
-10.71M
23,708.89%
-62.66M
484.80%
-73.57M
17.43%
-42.61M
42.09%
depreciation and amortization
54
-
-23.36M
-
-1.36M
94.16%
915K
167.03%
total other income expenses net
-8K
-
23.35M
291,975%
8.21M
64.85%
2.45M
70.12%
income before tax
-45K
-
-10.72M
23,726.67%
-39.31M
266.59%
-65.37M
66.30%
-40.16M
38.57%
income tax expense
-54
-
8K
14,914.81%
-23.70M
296,325%
-8.21M
65.37%
net income
-45K
-
-10.73M
23,744.44%
-15.61M
45.46%
-57.16M
266.22%
-40.16M
29.75%
weighted average shs out
5.20M
-
5.25M
1.08%
17.18M
227.04%
21.03M
22.43%
21.30M
1.26%
weighted average shs out dil
5.20M
-
5.25M
1.08%
17.18M
227.04%
21.03M
22.43%
21.30M
1.26%
eps
-0.01
-
-2.04
23,348.28%
-0.91
55.39%
-2.72
198.90%
-1.89
30.51%
epsdiluted
-0.01
-
-2.04
23,348.28%
-0.91
55.39%
-2.72
198.90%
-1.89
30.51%

All numbers in (except ratios and percentages)